Cargando…
Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine
BACKGROUND: Extra-cellular roles of Tat might be the main cause of maintenance of HIV-1 infected CD4 T cells or reservoir cells. We developed a synthetic vaccine based on a Tat variant of 101 residues called Tat Oyi, which was identified in HIV infected patients in Africa who did not progress to AID...
Autores principales: | Watkins, Jennifer D, Lancelot, Sophie, Campbell, Grant R, Esquieu, Didier, Mareuil, Jean de, Opi, Sandrine, Annappa, Sylvie, Salles, Jean-Pierre, Loret, Erwann P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434768/ https://www.ncbi.nlm.nih.gov/pubmed/16441880 http://dx.doi.org/10.1186/1742-4690-3-8 |
Ejemplares similares
-
HIV-1 Tat protein enhances Microtubule polymerization
por: de Mareuil, Jean, et al.
Publicado: (2005) -
Structure-function relationships of the HIV-1 Tat protein
por: Loret, Erwann P
Publicado: (2009) -
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial
por: Loret, Erwann P., et al.
Publicado: (2016) -
Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial
por: Loret, Erwann P., et al.
Publicado: (2016) -
Homonuclear (1)H NMR and circular dichroism study of the HIV-1 Tat Eli variant
por: Watkins, Jennifer D, et al.
Publicado: (2008)